In situ vaccination, low-dose targeted radionuclide therapy, and immune checkpoint inhibition eradicate poorly immunogenic metastatic tumors in murine cancer models
Cancer Immunol. Res., Jul 08 2026, | https://doi.org/10.1158/2326-6066.CIR-25-1475
Local TLR4 stimulation augments in situ vaccination induced via local radiation and anti-CTLA-4 checkpoint blockade through induction of CD8 T-cell independent Th1 polarization
J. Immunother. Cancer, Oct 2022, 10 (10) e005103 | https://doi.org/10.1136/jitc-2022-005103
